Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan’s PMDA Introduces Data Mining To Detect Adverse Events Earlier

This article was originally published in PharmAsia News

Executive Summary

Starting in fiscal year 2009, the Pharmaceuticals and Medical Device Agency of Japan plans to experiment with data mining techniques to detect earlier safety issues in drugs and medical devices. As a key element of a safety assurance system introduced in 2004, data mining will be used to understand drug risks at early stages and to prevent expansion of adverse events. PMDA said that the data mining system has been completed, and that a new adverse event database will also launch in 2009. Data mining has been used by the U.S. FDA and World Health Organization. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067910

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel